Cargando…

The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling

SIMPLE SUMMARY: We propose in this article to review the state of knowledge about predictive and prognosis biomarkers in metastatic breast cancer through the prism of molecular profiling studies. ABSTRACT: The past decade was marked by several important studies deciphering the molecular landscape of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verret, Benjamin, Bottosso, Michele, Hervais, Sofia, Pistilli, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454488/ https://www.ncbi.nlm.nih.gov/pubmed/36077738 http://dx.doi.org/10.3390/cancers14174203

Ejemplares similares

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
por: Toss, Angela, et al.
Publicado: (2017)

The incurable metastatic breast cancer experience through metaphors: the fight and the unveiling
por: Guité-Verret, Alexandra, et al.
Publicado: (2021)

Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast Cancer
por: Asghar, Uzma S., et al.
Publicado: (2022)

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
por: Koncina, Eric, et al.
Publicado: (2020)

Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival
por: Miglietta, F., et al.
Publicado: (2022)

Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
por: Rassy, Elie, et al.
Publicado: (2022)

RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro
por: Casimiro, Sandra, et al.
Publicado: (2013)

Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling
por: Kohsaka, Shinji, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Predictive Molecular Biomarkers and the Utility of Molecular Imaging in Common Gastrointestinal Tumors
por: Idowu, Michael O., et al.
Publicado: (2015)

Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy
por: Millis, Sherri Z., et al.
Publicado: (2015)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
por: Giannis, Dimitrios, et al.
Publicado: (2021)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes
por: Zelli, Veronica, et al.
Publicado: (2020)

Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer
por: Liu, Fangteng, et al.
Publicado: (2021)

Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease
por: Provenzano, Michele, et al.
Publicado: (2020)

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort
por: Shen, Fangfang, et al.
Publicado: (2023)

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer
por: Carlomagno, Nicola, et al.
Publicado: (2017)

An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
por: Saxby, Helen, et al.
Publicado: (2020)

CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
por: Li, Guo-Sheng, et al.
Publicado: (2023)

A profile of prognostic and molecular factors in European and Māori breast cancer patients
por: Dachs, Gabi U, et al.
Publicado: (2010)

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
por: Cirenajwis, Helena, et al.
Publicado: (2015)

Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer?
por: Grinda, T., et al.
Publicado: (2023)

Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer
por: Xu, Rong, et al.
Publicado: (2023)

Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics
por: Shiang, Christine, et al.
Publicado: (2010)

Resolving the Connectome, Spectrally-Specific Functional Connectivity Networks and Their Distinct Contributions to Behavior
por: Becker, Robert, et al.
Publicado: (2020)

Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast
por: Gatalica, Zoran, et al.
Publicado: (2015)

Deciphering the molecular landscape of metastatic lobular breast cancer
por: Dandachi, Nadia, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020)

Prognostic and Predictive Biomarkers in Familial Breast Cancer
por: Deb, Siddhartha, et al.
Publicado: (2023)

Prognostic molecular biomarkers in endometrial cancer: A review
por: Hernández, J. Edgardo, et al.
Publicado: (2019)

Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’: [ESMO Open Volume 7, Issue 2, April 2022, 100409]
por: Miglietta, F., et al.
Publicado: (2022)

Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)

Dedicator of Cytokinesis 4: A Potential Prognostic and Predictive Biomarker Within the Metastatic Spread of Breast Cancer to Bone
por: Brown, Janet E, et al.
Publicado: (2019)

Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study
por: Gupta, Anjali, et al.
Publicado: (2022)

An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer
por: Danforth, David N, et al.
Publicado: (2015)

Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer
por: Sivapiragasam, Abirami, et al.
Publicado: (2020)

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas
por: Topcagic, Jasmina, et al.
Publicado: (2018)

Epigenetic profiling for the molecular classification of metastatic brain tumors
por: Orozco, Javier I. J., et al.
Publicado: (2018)

Molecular profiling of driver events in metastatic uveal melanoma
por: Karlsson, Joakim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9blu3v5tfu0m5gu0049rcadi2q